Literature DB >> 14564325

Preprocedural white blood cell count and death after percutaneous coronary intervention.

Hitinder S Gurm1, Deepak L Bhatt, Ritesh Gupta, Stephen G Ellis, Eric J Topol, Michael S Lauer.   

Abstract

BACKGROUND: Elevated inflammatory markers are associated with worse outcome after percutaneous coronary artery interventions (PCI). An elevation in the white blood cell (WBC) count is a nonspecific response to inflammation. We hypothesized that an elevated WBC count would be a predictor of death in patients undergoing PCI.
METHODS: A total of 4450 patients undergoing percutaneous coronary artery intervention were divided into quintiles, based on their preprocedural WBC count (mean WBC count: quintile 1, 5.08 x 10(3)/muL; quintile 2, 6.58 x 10(3)/muL; quintile 3, 7.70 x 10(3)/muL; quintile 4, 9.14 x 10(3)/muL; and quintile 5, 13.4 x 10(3)/muL). Vital status was assessed through the use of the Social Security Death Index.
RESULTS: There were a total of 504 deaths over a follow-up period of 48 months. The best survival was seen in quintile 2, with an increase in long-term mortality rates seen with both a higher or a lower WBC count (P <.001). This J-shaped curve was preserved after multivariate adjustment, with the adjusted hazard ratio of mortality relative to quintile 2 being 1.95 (95% CI, 1.40 to 2.73) in quintile 1, 1.66 (95% CI, 1.18 to 2.33) in quintile 3, 2.31 (95% CI, 1.67 to 3.17) in quintile 4, and 2.42 (95% CI, 1.76 to 3.34) in quintile 5.
CONCLUSIONS: A low or an elevated preprocedural WBC count in patients undergoing PCI is associated with an increased risk of long-term death. Our result provides further evidence to support the important role of inflammation in coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564325     DOI: 10.1016/S0002-8703(03)00230-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Innate immunity has a dual effect on vascular healing: suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge.

Authors:  H Epstein; E Grad; M Golomb; N Koroukhov; E R Edelman; G Golomb; H D Danenberg
Journal:  Atherosclerosis       Date:  2007-12-11       Impact factor: 5.162

2.  Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study.

Authors:  Liding Zhao; Ya Li; Tian Xu; Yi Luan; Qingbo Lv; Yao Wang; Xue Lv; Guosheng Fu; Wenbin Zhang
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

3.  Predictors of preinterventional patency of infarct-related artery in patients with ST-segment elevation myocardial infarction: Importance of neutrophil to lymphocyte ratio and uric acid level.

Authors:  Durmuş Yıldıray Sahin; Mustafa Gür; Zafer Elbasan; Ali Yıldız; Zekeriya Kaya; Yahya Kemal Içen; Ali Kıvrak; Caner Türkoğlu; Remzi Yılmaz; Murat Caylı
Journal:  Exp Clin Cardiol       Date:  2013

4.  Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.

Authors:  Kyoung Im Cho; Soe Hee Ann; Gillian Balbir Singh; Ae-Young Her; Eun-Seok Shin
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

5.  Association of lymphocyte to monocyte ratio with severity of coronary artery disease.

Authors:  Shu Gong; Ximei Gao; Fubiao Xu; Zhi Shang; Shuai Li; Wenqiang Chen; Jianmin Yang; Jifu Li
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

6.  Combination of White Blood Cell Count to Mean Platelet Volume Ratio and Neutrophil-to-Platelet Ratio Predicts Long-Term Adverse Events in Patients with MINOCA.

Authors:  Ayman A Mohammed; Lu Liu; Redhwan M Mareai; Abdul-Quddus Mohammed; Guoqing Yin; Shekhar Singh; Yawei Xu; Fuad A Abdu; Wenliang Che
Journal:  Mediators Inflamm       Date:  2022-08-16       Impact factor: 4.529

7.  Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.

Authors:  Kenneth Mangion; David Carrick; Barry W Hennigan; Alexander R Payne; John McClure; Maureen Mason; Rajiv Das; Rebecca Wilson; Richard J Edwards; Mark C Petrie; Margaret McEntegart; Hany Eteiba; Keith G Oldroyd; Colin Berry
Journal:  Heart       Date:  2016-08-08       Impact factor: 5.994

Review 8.  The Role of Hematological Indices in Patients with Acute Coronary Syndrome.

Authors:  Jan Budzianowski; Konrad Pieszko; Paweł Burchardt; Janusz Rzeźniczak; Jarosław Hiczkiewicz
Journal:  Dis Markers       Date:  2017-10-03       Impact factor: 3.434

9.  Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention.

Authors:  Runzhen Chen; Chen Liu; Peng Zhou; Yu Tan; Zhaoxue Sheng; Jiannan Li; Jinying Zhou; Yi Chen; Li Song; Hanjun Zhao; Hongbing Yan
Journal:  Mediators Inflamm       Date:  2020-04-17       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.